ABSORICA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Absorica, and what generic alternatives are available?
Absorica is a drug marketed by Sun Pharm Inds Inc and Sun Pharm and is included in two NDAs. There are two patents protecting this drug and five Paragraph IV challenges.
The generic ingredient in ABSORICA is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Absorica
A generic version of ABSORICA was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ABSORICA?
- What are the global sales for ABSORICA?
- What is Average Wholesale Price for ABSORICA?
Summary for ABSORICA
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 10 |
Patent Applications: | 7,499 |
Drug Prices: | Drug price information for ABSORICA |
Drug Sales Revenues: | Drug sales revenues for ABSORICA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ABSORICA |
What excipients (inactive ingredients) are in ABSORICA? | ABSORICA excipients list |
DailyMed Link: | ABSORICA at DailyMed |
Recent Clinical Trials for ABSORICA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Children's Oncology Group | Phase 2 |
National Cancer Institute (NCI) | Phase 2 |
Sun Pharmaceutical Industries Limited | Phase 4 |
Pharmacology for ABSORICA
Drug Class | Retinoid |
Paragraph IV (Patent) Challenges for ABSORICA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ABSORICA | Capsules | isotretinoin | 25 mg | 021951 | 1 | 2016-05-16 |
ABSORICA | Capsules | isotretinoin | 35 mg | 021951 | 1 | 2015-11-25 |
ABSORICA | Capsules | isotretinoin | 10 mg | 021951 | 1 | 2013-06-20 |
ABSORICA | Capsules | isotretinoin | 20 mg | 021951 | 1 | 2013-01-07 |
ABSORICA | Capsules | isotretinoin | 40 mg | 021951 | 1 | 2012-12-31 |
US Patents and Regulatory Information for ABSORICA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | AB2 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-006 | Nov 5, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Sun Pharm | ABSORICA LD | isotretinoin | CAPSULE;ORAL | 211913-001 | Nov 5, 2019 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ABSORICA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-004 | May 25, 2012 | ⤷ Sign Up | ⤷ Sign Up |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-005 | Aug 15, 2014 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ABSORICA
See the table below for patents covering ABSORICA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 0224172 | ⤷ Sign Up | |
Portugal | 1318791 | ⤷ Sign Up | |
European Patent Office | 1318791 | COMPOSITION PHARMACEUTIQUE SEMI-SOLIDE D'ISOTRETINOINE (PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |